Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,309.60
(
0.73%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.59
(
-0.06%
)
Bitcoin
74,146.74
(
0.28%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3206
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 144913

Wednesday, 07/04/2012 3:43:08 PM

Wednesday, July 04, 2012 3:43:08 PM

Post# of 257253
On the plus side, it is nice to see Dr. Flaherty's involvement in the MNTA M402 study.

http://harvardmagazine.com/harvard-in-the-news/cancer-pioneer

I do think standards of care in pancreatic may be a moving target as 402 progresses, which adds risk.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now